Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00574587
Title Trial for Locally Advanced Her2 Positive Breast Cancer Using Paclitaxel, Trastuzumab, Doxorubicin and Cyclophasmide on a Weekly Basis
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Montefiore Medical Center
Indications

Her2-receptor positive breast cancer

Therapies

Paclitaxel + Vorinostat

Trastuzumab

Cyclophosphamide + Doxorubicin

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Montefiore Medical Center Bronx New York 10461 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field